Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Shares Outstanding (Diluted Average) (2022 - 2025)

Dna X (SONM) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $984927.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) rose 280.59% year-over-year to $984927.0, compared with a TTM value of $984927.0 through Sep 2025, up 280.59%, and an annual FY2024 reading of $4.7 million, up 10.04% over the prior year.
  • Shares Outstanding (Diluted Average) was $984927.0 for Q3 2025 at Dna X, down from $7.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $41.1 million in Q1 2023 and bottomed at $258788.0 in Q3 2024.
  • Average Shares Outstanding (Diluted Average) over 4 years is $12.4 million, with a median of $4.7 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) tumbled 94.08% in 2024, then soared 280.59% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $28.9 million in 2022, then tumbled by 85.16% to $4.3 million in 2023, then rose by 10.04% to $4.7 million in 2024, then crashed by 79.12% to $984927.0 in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for SONM at $984927.0 in Q3 2025, $7.7 million in Q2 2025, and $5.9 million in Q1 2025.